| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | UHNBreast | pan-cancer | AAC | -0.017 | 1 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |
| mRNA | IC-87114 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | DBeQ | CTRPv2 | pan-cancer | AAC | -0.00093 | 1 |
| mRNA | BMS-195614 | CTRPv2 | pan-cancer | AAC | 0.00076 | 1 |
| mRNA | BRD-K29313308 | CTRPv2 | pan-cancer | AAC | 0.00071 | 1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.00092 | 1 |
| mRNA | navitoclax:PLX-4032 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00014 | 1 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0001 | 1 |
| mRNA | KH-CB19 | CTRPv2 | pan-cancer | AAC | 2e-05 | 1 |